1. Home
  2. ZNTL vs BLUW Comparison

ZNTL vs BLUW Comparison

Compare ZNTL & BLUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$4.09

Market Cap

313.9M

Sector

Health Care

ML Signal

HOLD

BLUW

Blue Water Acquisition Corp. III Class A Ordinary Shares

N/A

Current Price

$10.28

Market Cap

331.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ZNTL
BLUW
Founded
2014
2024
Country
United States
United States
Employees
N/A
2
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
313.9M
331.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ZNTL
BLUW
Price
$4.09
$10.28
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$6.60
N/A
AVG Volume (30 Days)
1.1M
19.9K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
18.03
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$9.94
52 Week High
$6.95
$10.41

Technical Indicators

Market Signals
Indicator
ZNTL
BLUW
Relative Strength Index (RSI) 50.58 54.33
Support Level $3.75 $10.24
Resistance Level $4.34 $10.40
Average True Range (ATR) 0.30 0.02
MACD -0.06 0.00
Stochastic Oscillator 26.72 60.00

Price Performance

Historical Comparison
ZNTL
BLUW

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

About BLUW Blue Water Acquisition Corp. III Class A Ordinary Shares

Blue Water Acquisition Corp III is a blank check company.

Share on Social Networks: